Post-approval studies (Phase 4)Study completedNCT03903133
What this trial is testing
Endothelial Monocyte-activating Polypeptide-II in Egyptian Sickle Patients
Who this might be right for
Sickle Cell Disease
Ain Shams University 50
Showing 10 of 10 results